Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS - Wikidata - wikimedia - TriplyDB

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

http://www.wikidata.org/entity/Q37415788

about

A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system.EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy.Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial.Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis.Neonatal Bacillus Calmette-Guérin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice.The interplay between bacillus Calmette-Guérin and Treg cells and its role to prevent or cure inflammatory diseases.Noise in multiple sclerosis: unwanted and necessary.BCG-associated heterologous immunity, a historical perspective: experimental models and immunological mechanisms.TNF, TNF Inducers and TNFR2 Agonists: A New Path to Type 1 Diabetes Treatment.Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop.Vaccines in Multiple Sclerosis.Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploited.Vaccines and multiple sclerosis: a systematic review.Conflicting Role of Mycobacterium Species in Multiple Sclerosis.BCG and protection against inflammatory and auto-immune diseases.The role of the interleukin-1 family in trained immunity.Protective effects of carbonyl iron against multiple low-dose streptozotocin-induced diabetes in rodents.Vaccines and multiple sclerosis.A New Venue of TNF Targeting.Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations.

P2860

Q30844551-820E420D-BF81-4B60-B510-2C2C26471081 Q33784457-187DDF8C-962E-410E-873D-F6D944D789DD Q35597330-A4F1CF4B-2757-431D-B45F-BEDA440BE0E1 Q36001597-F6E77C2B-BF79-41A1-AE2D-F600F2DC72A6 Q36930224-375488A7-CC94-4504-BAB8-AA59B9FEC0FE Q37082976-AE30FCD1-B188-408D-8A2F-8607C922071B Q38212488-037D3BFB-6D36-468D-B1D6-0DEF073F4912 Q38263875-FB9AD495-CCE2-4C08-8409-7B2557F86248 Q38312186-615332F9-A5C5-4D95-B65C-90722B70F15D Q38607412-1D882A6B-18EE-4CE1-8BE4-D6B9D3F3FB5C Q38663577-664FE4AA-946B-426B-86CD-7D97D8933A9C Q38752982-7D108CB7-5B8B-40D5-98A4-041B1A7059AE Q38846730-932F3D3F-6D8B-44FA-A7CD-16007886277E Q38948785-AEFCDADD-6922-49EC-BA19-E70D52C95F4A Q39349951-CC894522-0329-43A5-A00A-1A023C7E7381 Q40203403-038A289B-1D45-400E-B12B-6F25F3BCAFD3 Q48105533-24EDD9F4-1286-45EF-A2B5-BCD133B225FC Q48159465-4AB3FB12-37BC-44AD-BE9A-61AD689A36DF Q50080890-13635AA6-1F90-46A2-9DB0-0520A4849160 Q55001725-DBE62601-637F-466E-9C0D-25A5A6263ED8 Q55290300-E5030960-58C3-4D57-9FE9-A1BBEEB02DB5

P2860

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

http://www.wikidata.org/entity/Q37415788

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

@en

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

@nl

type

label

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

@en

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

@nl

prefLabel

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

@en

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

@nl

P1433

Q37415788-BF00CAB4-6E95-4B1A-BC77-2B47DD9471D1

P1476

Q37415788-CA6EFB29-30BD-43C7-BB73-842B191F1703

P2093

Q37415788-11E6EBDC-8FC3-4211-B463-EA2EED47F788

Q37415788-15F75EBD-950F-49BB-9A64-7B35E333E353

Q37415788-5BFAA85F-8B53-43B0-8A91-5ACA55672264

Q37415788-5C39D2E6-F5E0-4F6D-AB08-21BD6AD1D42C

Q37415788-5EBBF042-44E0-42E5-90AB-1EC6C5A6D7F3

Q37415788-75853DF0-B63F-44A6-9414-E2F2ECCFFE74

Q37415788-8BA29C9F-04A5-4EB4-AA27-D2AFE03C1E28

Q37415788-92829CF3-8BA3-4204-B410-2B5991E55878

Q37415788-969A51D5-32F1-452D-AB0C-B4025BE46815

Q37415788-BD19AEC0-E8FD-4CE3-9F36-7E745FEAA331

P2860

Q37415788-08ECAF67-24E3-4F97-BA54-CAF9BC3365F9

Q37415788-0D49734B-758E-4313-8672-08D748CD2C80

Q37415788-0E6AA4B5-8883-4327-A194-6CC719B472ED

Q37415788-1242CFA8-9904-46BB-A315-ED5F80E7AB29

Q37415788-13D839DA-2E9A-4F1C-9488-B1DC838641D4

Q37415788-13E85673-AB1A-48E3-AF9C-7E2605DBF030

Q37415788-1762D926-6C98-4A2E-B075-64724B0D26BC

Q37415788-1B60D7DA-3CAB-4F91-B6FD-5D1568048090

Q37415788-28A72AF1-8EA0-4352-83A5-7C20EC955B5A

Q37415788-3118A60A-9184-4706-B908-26B9AD22F8E8

P304

Q37415788-6F18F608-80AD-48C9-8B44-1E34C4CFBE69

P31

Q37415788-C9F5AE16-3746-436A-9EB3-7A9A58FBCF12

P356

Q37415788-6038A3F9-09EA-4AEA-9F13-963837E29628

P407

Q37415788-EB1F4EAB-C165-4E82-95CC-F159DF1DB061

P433

Q37415788-D0B989F7-4746-4C5F-A9EB-C8F26D92EE06

P478

Q37415788-D51424D6-8D9B-457F-9A51-1C1B1AE3DAC3

P50

Q37415788-33D27651-F7F1-4A89-A6FE-7A20E51E99DF

Q37415788-462AA654-804A-4920-9268-997150CE19EB

Q37415788-B2720A94-5836-485F-BF87-662B2C552E3C

Q37415788-BBB513B3-B106-43BC-983D-B937B000A37F

Q37415788-C4554FC1-860F-4867-989D-7014EA9BE22A

Q37415788-FF74771B-4EBD-470C-A348-B72715C4F9FE

P577

Q37415788-767C19BF-C179-4BE3-B695-E783C35285D6

P698

Q37415788-E2E631CD-FF11-4B48-B4CD-36104ADE532E

P932

Q37415788-FDAC4B98-C57F-4E11-AF98-6DDD10357C18

P356

01.WNL.0000438216.93319.AB

P1433

P1476

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

@en

P2093

Andrea Visconti

http://www.w3.org/2001/XMLSchema#string

Carla Buttinelli

http://www.w3.org/2001/XMLSchema#string

Carlo Pozzilli

http://www.w3.org/2001/XMLSchema#string

Domenico Caputo

http://www.w3.org/2001/XMLSchema#string

Emanuele Tinelli

http://www.w3.org/2001/XMLSchema#string

Giulia Coarelli

http://www.w3.org/2001/XMLSchema#string

Laura Mendozzi

http://www.w3.org/2001/XMLSchema#string

Marco Frontoni

http://www.w3.org/2001/XMLSchema#string

Marco Salvetti

http://www.w3.org/2001/XMLSchema#string

Pietro Cecconi

http://www.w3.org/2001/XMLSchema#string

P2860

Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes

Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

Association between parasite infection and immune responses in multiple sclerosis

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.

Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.

Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.

Islet regeneration during the reversal of autoimmune diabetes in NOD mice.

P304

41-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/01.WNL.0000438216.93319.AB

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

Mario Quarantelli

Roberta Lanzillo

Giovanni Ristori

Claudio Gasperini

Nicola Vanacore

P577

2013-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24306002

http://www.w3.org/2001/XMLSchema#string

P932

3873620

http://www.w3.org/2001/XMLSchema#string